Recognizing the risk of Propofol-related infusion syndrome (PRIS) with propofol, we are looking to learn what safety measures health systems have implemented around the use of propofol. I would appreciate your responses to the following questions and any additional feedback:

Hi all,

I am currently piloting safety walk rounds at my institution. In current state, the Patient Safety Officer and I will go to random floors monthly and speak with front line staff to see how things are going and if there are any opportunities. It has been successful so far but there is a gap in structure (i.e. we like to include nursing managers and sometimes they are unavailable), documentation, follow up, and report outs from the walk rounds.